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ABSTRACT 
Inositol 1,3,4,5,6-pentakisphosphate 2-kinases (IP5 
2-Ks) comprise a family of enzymes in charge of 
synthesizing inositol hexakisphosphate (IP6) in 
eukaryotic cells. This protein and its product     IP6 
conclusion, our findings have uncovered distinct 
features of a mammalian IP5 2-K and set the stage 
for investigations into protein-protein or protein- 
RNA interactions important for IP5 2-K function 
and activity. 
present many roles in cells, participating in mRNA    
export,  embryonic  development,  and   apoptosis. 
We reported previously that the full-length IP5 2-K 
from Arabidopsis thaliana (At) is a zinc metallo- 
enzyme including two separated lobes (the N and 
C lobes). We have also shown conformational 
changes in IP5 2-K and have identified the residues 
involved in substrate recognition and catalysis. 
However, the specific features of mammalian IP5 
2-Ks remain unknown. To this end, we report here 
the first structure for a murine IP5 2-K in complex 
with ATP/IP5 or IP6. Our structural findings 
indicated that the general folding in N and C lobes 
is conserved with AtIP5 2-K. A helical scaffold in 
the C lobe constitutes the inositol phosphate (IP)- 
binding site, which, along with the participation of 
the N lobe, endows high specificity to this protein. 
However, we also noted large structural 
differences between the orthologous from these 
two eukaryotic kingdoms. These differences 
include a novel zinc-binding site and regions 
unique to the mammalian IP5 2-K, as an 
unexpected basic patch on the protein surface.    In 
Inositol 1,3,4,5,6-pentakisphosphate 2- 
kinase (IP5 2-K) is a key enzyme of higher inositol 
phosphate (inositide, IP) metabolism. IP5 2-K is 
present from yeast to mammals and catalyzes the 
synthesis of phytic acid (inositol hexakisphosphate 
or IP6) from IP5 and ATP (1). A variety of roles 
have been proposed for this enzyme and its  
product IP6 (2), in DNA repair (3), mRNA editing, 
export  and  degradation  (4,5),  vesicle trafficking 
(6) and protein ubiquitylation (7). At a molecular 
level, IP6 acts as a cofactor for proteins with DNA- 
dependent protein kinase activity in non- 
homologous end joining (8) and with GLE1 in 
mRNA export (4). IP6 also can act as a folding 
factor as in the case of adenosine deaminase that 
participates in editing of mRNA and tRNA (5). In 
addition, IP6 is the precursor of inositol 
pyrophosphates, essential for cellular energy 
homeostasis, signal transduction control and 
apoptosis (9,10). Mice embryos with IP5 2-K 
deletion  do  not  survive  more  than  a  few weeks 
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(11). More recently a role in ribosomal rRNA 
synthesis independent of IP5 2-K catalytic function 
has been proposed for the human enzyme (12), 
which has been shown to co-localize with mRNA 
either in nucleus or cytoplasm (13). All these 
findings increase the potential of this enzyme as an 
attractive target. 
IP5 2-K belongs to the inositol 
polyphosphate (IPK) structural family that include 
enzymes capable of phosphorylating hydroxyls at 
different positions of the inositol ring starting from 
inositol 1,4,5-trisphosphate (IP3), a well-known 
second messenger responsible for calcium 
mobilization (14). These phosphorylation events 
occur in combination with another family of 
inositol kinases that adopts a “ATP-grasp  like” 
fold (15,16). Both families together cover a great 
range of phosphorylation reactions on the six -OH 
positions of the myo-inositol ring and even on 
those already phosphorylated (15,17,18). Many of 
these enzymes present redundant abilities acting  
on similar substrates or they bind an inositide in 
different orientations that is thus phosphorylated in 
different positions (19). In contrast, IP5 2-K is the 
unique IPK whose physiological role is the 
phosphorylation of the axial 2-OH position of myo 
inositol, the other five hydroxyls being in 
equatorial positions. It is also a very specific 
enzyme and, together with IP3 3-K, phosphorylates 
just one position of inositol (20,21). 
IPK enzymes are classified as a structural 
subgroup of protein kinases (PK) family, since 
they conserve a few features including a fold in 
two separated lobes (N- and C-lobe) and similar 
nucleotide recognition mode (22). In addition, the 
core of the N-lobe is conserved as well as the 
presence of a few residues involved in catalysis 
and in nucleotide phosphates binding. In 2004, the 
first structure of an IPK was described, that from 
IP3 3-K (23). Since then, the structure of at least 
one member of each IPK subfamily has been 
reported (23-26). In summary, the IPK family 
presents a specific and characteristic fold in the C- 
lobe different from PKs, having a -sheet  core 
with helical insertions showing a great range of 
sizes depending on the IPK class. These helical 
regions are involved in substrate binding and have 
been named by us as IP-lobe or CIP-lobe (19). 
Thus, promiscuous IPKs, such as the IP 
multikinases (IPmKs), have a single helix inserted 
showing  an  open  active  site  able  to  cope  with 
 
various substrates and products, whereas more 
specific enzymes as IP3 3-K and IP5 2-K show 
larger helical scaffolds. In fact, IP5 2-K shows the 
most elaborated helical region. 
The full length structure of IP5 2-K from 
Arabidopsis thaliana (AtIP5 2-K) is the only one 
known for this subfamily (25). It shows the 
features described above and that it is a zinc 
metallo-enzyme, for which a structural role has 
been proposed (25). We subsequently captured 
different IP5 2-K conformations by X-ray 
Crystallography (27) displaying open, half-closed 
or closed conformations, as the nucleotide and/or 
the inositide are absent or present in the active site. 
Extensive work by others and us has identified the 
residues involved in substrate recognition and 
catalysis and has depicted the participation of the 
N-lobe in achievement of a productive 
conformation (25,27-30). The structure of AtIP5 2- 
K was an important advance for this field but, 
nevertheless, the specific features of mammal IP5 
2-K remain unknown. IP5 2-K family shows 
moderate sequence conservation across  the 
species. In particular, mammalian enzymes show 
different insertions and do not conserve the zinc 
site found in the plant enzyme, making difficult to 
obtain a good sequence alignment. From its 
sequence motifs, putative zinc binding residues 
have been proposed in human IP5 2-K (13). 
However, if mammal IP5 2-K is a Zinc 
metalloenzyme and the putative role for this metal 
awaits further studies. Because of the significance 
of IP5 2-K to proper cell functioning and the many 
roles of its product IP6, it is important to 
understand the molecular basis that underlies this 
enzyme function. In this work, we  have 
determined the mouse IP5 2-K structure in  
presence of inositide showing that, although this 
enzyme conserves features with the plant enzyme, 
it differs significantly in many aspects. Our results 
define the specific features of mammal IP5 2-Ks.  
In addition, we present here valuable information 
that could help in understanding IP5 2-K functions 
beyond its catalytic activity as its role in ribosomal 
RNA synthesis (12) 
 
 
RESULTS 
The structure of IP5 2-K mammalian 
isoform-We have solved the structure of Mus 
musculus IP5 2-K (mIP5 2-K) at 2.4 Å    resolution 
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(Table 1) from a truncated form lacking the 21-C- 
terminal residues (∆C-mIP5 2-K). Noticeably, mIP5 
2-K crystals were not obtained in absence of the 
inositide. The structure for mIP5 2-K in presence  
of one or both ligands, forming binary complexes 
(IP6) or ternary complexes (IP5+ATP) is presented 
(Fig. S1). In addition, we present two different 
crystal forms, including one or two molecules in 
the asymmetric unit respectively, the first showing 
much better resolution (2.4 vs 3.2 Å). As mouse 
and human IP5 2-K isoforms shares 91% of 
sequence identity, we propose the structure of the 
mouse enzyme as a template for the mammalian 
IP5 2-Ks. 
Mouse IP5 2-K folds in two lobes, N- and 
C- terminal lobes, connected by a hinge   therefore 
conserving the general fold scheme of PKs and 
IPKs and in a similar way, both lobes co-ordinate 
the nucleotide between them (Fig. 1A). The N-lobe 
core forms a -sheet formed by five antiparallel - 
strands (1- 5) showing two helical segments. 
The first helical segment (N-I) harbors 1, 
equivalent to the helix C characterized in all 
protein kinases, while the second one (N-II) is a 
specific insertion different in every IPK subfamily. 
A role of this region for substrate binding in the 
IP5 2-K subfamily has been previously reported by 
others (29) and by us (25,27). Regarding the C- 
lobe, it also presents a -sheet core formed by five 
antiparallel -strands (6-10). Three helical 
segments are inserted in the -sheet core. These 
segments altogether form a large helical ensemble 
named as CIP lobe in the structure of AtIP5 2-K 
(25), and each of them is consequently named as 
CIPI, CIPII and CIPIII. The CIP lobe represents 
more than a half of the protein and is specific to 
IP5 2-K enzymes. It creates a scaffold that builds  
up most of the inositide substrate binding site. The 
five loops (CL1-CL5) joining the CIP region to the 
C-lobe -sheet core are essential since they play a 
key role in substrate binding and catalysis. (Fig. 
1B and 2). 
 
mIP5 2-K active site and substrates 
recognition-A general view of IP5 2-K substrate 
recognition is shown in Fig. 2A and detailed in 
Table S1. The adenine is strongly recognized 
through polar and hydrophobic interactions with 
both protein lobes and the hinge connecting them 
(Fig. 2B). In particular, it forms polar  interactions 
 
with His14 and the backbones of Pro116 and 
Leu118. The ribose OHs interact with the C-lobe 
residues Glu136 and Arg209. The triphosphate 
moiety is tightly bound to the N-lobe of the 
enzyme through polar interactions and to the C- 
lobe through two magnesium ions. In particular, 
phosphate interaction with the residue Arg33, with 
a flexible loop (G-loop, residues Gly15-Ser20) and 
with an acidic residue (Asp437) through the Mg 
ions is conserved throughout the PK superfamily 
and are essential for nucleotide binding and kinase 
activity. 
Regarding the inositide substrate, IP5 is 
tightly bound to the enzyme through its five 
phosphates (Fig. 2C). A total of fourteen residues 
coordinate the phosphate groups, two of them 
through water molecules and eight of them being 
lysine or arginine. P1 and P3 are coordinated by 
both lobes, while P4-P5 are coordinated 
exclusively by the C-lobe. Residues from the N- 
lobe involved in P1 and P3 binding come from the 
segment N-II (Arg100) and the G-loop (Asn18 and 
Lys19) mentioned above. Residues from the C- 
lobe involved in coordination of the five 
phosphates come from the CIP lobe and its CLs. 
Fig. 2C and Table S1 show all the polar 
interactions produced with the inositide  
phosphates (P1: Asn18, Arg100, Lys 138, Lys173 
and Asn206; P3: Asn18, Lys19 and Lys441; P4: 
Gln449; P5: with Lys140, Arg 160 and His164 
through water molecules and P6: Lys138, Lys140, 
Lys168, Asn206 and water mediated with 
Asn207). The tight and extensive recognition 
explains the high specificity of this enzyme. 
Human IP5 2-K displays a 0.43 µM Km for IP5 (31) 
in good agreement to the value obtained for mIP5 
2-K by us (0.29 µM) (Fig. 3A) and in contrast with 
the low tens of micromolar value reported for the 
AtIP5 2-K (22 M) (32). A possible explanation to 
the different Km found in the plant enzyme might 
be related to some differences found in enzymes 
from both kingdoms either in the inositide 
recognition mode or in the constraints introduced 
by the Zinc binding site (see later). 
Six residues from the CLs form the 
interface of substrates recognition, generating  a 
net of interactions including the Mg ions  (Fig. 
2D). Residues Lys138 and Asp400 make direct 
interaction with P and/or the nucleophile 2-OH. 
The distance between the 2-OH and P oxygen   is 
3.2     Å     suggesting     an     in-line  transference 
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mechanism probably in agreement with an 
associative mechanism. P is oriented through a 
Mg ion (Mg1) coordinated to Asp437 and to 
Asp439 in a second sphere. Asp437 also 
coordinates a second Mg ion (Mg2) together with 
Ser402 through a water molecule. Comparison of 
the ternary and binary complexes  (IP5 2- 
K/IP5/ATP vs IP5 2-K/IP6) shows that there is no 
significant structural variation among  them 
(r.m.s.d is 0.377 Å for 403 C atoms). The IP6 
shows similar interactions, with P2 remaining at 
the substrates interface region described above. 
A BLAST search using  mIP5 2-K 
sequence and limited to mammals (taxid:40674) 
show that all residues coordinating the nucleotide 
and inositide are absolutely conserved, just a 
couple of residues showing a conservative change 
in some species. 
Unexpectedly, the formation of the ternary 
complex (mIP5 2-K + IP5 + ATP) was achieved by 
protein incubation with IP6 and ADP (Fig. S1). 
Therefore, we checked that our crystallized mIP5 
2-K samples are able to catalyze both the forward 
(Fig. 3B) and reverse (Fig. 3C) reactions in 
solution. In agreement, the plant enzyme is highly 
reversible with an equilibrium constant in the 
forward ‘kinase’ direction of approximately 14 
(20). By ion-pair reverse phase HPLC, we were 
also able to confirm the production of ATP from 
IP6 and ADP (data not shown). 
 
Mammal IP5 2-Ks share a zinc binding site 
with a novel structure-mIP5 2-K presents two zinc 
ions in its structure, one in the CIP-lobe (Zn1) and 
the other close to the hinge region (Zn2) (Fig. 1 
and 4). In fact, Zn1 is present in all the crystals 
obtained whereas Zn2 was only detected in the 
low resolution ∆C-mIP5 2-K crystals in which the 
two molecules in the asymmetric unit interact 
through the hinge region probably fixing a 
conformation captured by crystallography (Fig. 
S2). 
The Zn1 site is formed by residues from 
two CIP lobe elements: Cys159, Cys162 and 
Cys181 from CIP-I and Cys291 from CIP-II (Fig. 
4A). This site presents the typical zinc geometry 
and coordination though it has no homologues in 
the structural databases using DALI server (33). 
The two first cysteines from CIP-I are located in 
an helix, separated by two residues and could 
remind  a  partial  zinc-finger;  however  the fourth 
 
ligand breaks any resemblance since it comes from 
a position very distant in sequence. In fact, Cys291 
comes from a very long loop inserted into two 
helices that cross over the back of the CIP-lobe 
(Fig. 5). We have selected Cys181 and Cys291 as 
candidates for the mutagenic study (Fig. 4C). 
However, there was no expression of C181S mIP5 
2-K mutant in the conditions reported herein for 
the wild-type protein. This suggests that Zn1 site 
formation could be essential for proper protein 
folding. By contrast, C291S mIP5 2-K mutant 
expression levels are in the same order to the wild- 
type being only 2-fold decreased. In spite of this, 
the impact of this mutation on enzyme activity is 
very high, since the mutated sample retains less 
than 10% of enzyme activity (Fig. 4C). In this line, 
it is worth mentioning that the two first cysteines 
of this zinc site are in helix 4, an element that 
provides four residues for the inositide substrate 
binding (Fig. 2A). We also consider that this fact 
could have some effect in obtaining a lower Km for 
the substrate in mIP5 2-K. 
Regarding   Zn2,   it   is   created   by   two 
residues from the hinge (His125 and His129) and 
one residue from the C-lobe (Cys410) (Fig. 4B). 
Mutation of residues His129 and Cys410 to serine 
produces samples with a moderate decrease in 
enzymatic activity revealing that the Zn2 is not 
critical for protein function (Fig. 4C). A possible 
explanation for the greater decrease found in 
H129S mutant could its key location in the hinge, 
an element important for enzyme flexibility. 
We have subsequently evaluated the metal 
content in mIP5 2-K samples  by  Inductively  
Coupled Plasma-Optical Emission Spectroscopy 
(ICP-OES) (Fig. 4D). We confirmed that mIP5 2-K   
is a Zinc metelloenzime (Table S2). Unexpectedly, 
wild-type samples purified as LSLt-tagged protein 
exhibit a zinc:protein molar ratio of 0.6:1. An 
insufficient supply of zinc could also explain the 
difficulties encountered in the  crystallization  
process of this enzyme due to structural 
inhomogeneity. However, attempts  to  add  zinc 
from different salts to the  crystallization  drops  
failed since the protein precipitated. We found a 
zinc:protein molar ratio of 0.8:1, 0.4:1, and 
0.7:1 for H129S, C291S, and C410S, mutants 
respectively. As expected, mutation on residue 
Cys291 (Zn1 site) yields an enzyme with  less 
content of zinc than the wild type (Fig. 4D  and  
Table     S2).     By     contrast,     mutation     of  Zn2 
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coordinating residues (His129 and Cys410) yield 
samples with no reduction in the zinc content (Fig. 
4D and Table S2). Therefore, we further analyzed 
the features of the C291S mutant by Circular 
Dichroism (CD) (Fig. 4E). We found that both, 
WT (wild type) and C291S mIP5 2-K samples 
display a similar Far-UV CD spectra suggesting 
that they share similar secondary structural 
elements. However, thermal denaturation followed 
by CD revealed that the mutated sample exerts an 
apparent Tm (32 ºC) drastically reduced compared 
to that of the WT sample (43 ºC). 
In conclusion, our results suggest that Zn1 
is necessary for protein folding and stability. 
Furthermore, the reduced capacity of C291S 
mutant to bind zinc correlates with a high 
reduction in protein activity (Fig. 4C and 4D). In 
agreement, IP5 2-Ks from mammals show 
conservation only in the Zn1 site, its four cysteine 
ligands being fully conserved. Therefore, Zn1 is 
key in all mammal IP5 2-K enzymes whereas Zn2 
could be an artifact of crystallization. 
 
Mammal and plant IP5 2-Ks show three 
large structural divergences-Up to now, the other 
IP5 2-K with known structure is that from A. 
thaliana (25). A C superposition of mIP5 2-K 
onto AtIP5 2-K (pdb code 2xan) overlays 327 
residues (out of 468 in mIP5 2-K) with an r.m.s.d.= 
1.2 Å. A good sequence alignment between both 
enzymes has remained elusive since their sequence 
homology is not very high (24% identity and 38% 
similarity) and they present different insertions. A 
structural alignment of both IP5 2-K isoforms is 
shown in Fig. 5. While the topology of N- and C- 
lobe cores and substrate binding region are quite 
conserved, both enzymes present multiple 
dissimilarities. 
The most predominant divergences are 
found within three regions, which show large 
differences in their sequence, length and topology 
(Fig. 5 and 6A-D). The first main difference (D1) 
is located in N-I region, AtIP5 2-K having an 
insertion not present in the mammal enzyme (Fig. 
6B). A possible function of this segment will be 
discussed below. The second clear difference (D2) 
is concentrated within the CIP-II region (Fig. 6C). 
Mouse IP5 2-K presents a long and flexible loop 
(Ser272-Gly316, 45 residues) that crosses back the 
whole CIP (Fig. 5 and 6C). Interestingly, this loop 
is   the   one   that   provides   a   cysteine   residue 
 
(Cys291) that completes the Zn1 site present in 
mIP5 2-K (Fig. 4). In addition, this loop seems to 
stabilize the protein, since it packs with several 
regions of the enzyme, including both lobes, but 
mainly the CIP-lobe. In particular, it makes 
hydrogen bonds through four residues (Leu283, 
Arg289, Glu292 and Ser294), and shows strong 
hydrophobic interactions through seven residues 
(Leu281,    Leu283,    Pro288,    Ala293,   Pro295, 
Leu313, Pro314) (Fig. 6E). These residues are 
fully or highly conserved along the mammal 
isoforms. Only residues Leu283 and Arg289 show 
a great variation, both involved in hydrogen bonds 
through their main chain atoms with other parts of 
the protein (Fig. 6E). Finally, a third difference 
(D3) is shown in a region also located in the CIP- 
II (Fig. 6D). Precisely, AtIP5 2-K presents a zinc 
site located in this region (25) that is shorter than 
and completely different from that found in mIP5 
2-K (Fig. 6C and 6D). 
Noticeably, different regions of the two 
isoforms seem to share roles. On one hand, D1 and 
D3, from AtIP5 2-K and mIP5 2-K  respectively 
(Fig. 6B and 6D), are both stabilizing essential 
zones of the enzyme, as are 1 (Asn54-Phe66, 
analogous to protein kinases C) and other CIP 
residues. Some relevant interactions of these 
regions are shown in Fig. 6F and 6G. Among 
them, it is worth to mention the central role of 
Tyr363, Phe367 and Tyr368 in mIP5 2-K (Fig. 6F), 
residues absolutely conserved in the mammal IP5 
2-K isoforms. AtIP5 2-K presents residues with 
similar role to Tyr363 (Leu75) and  Phe367 
(Trp69) that interact with equivalent regions of the 
protein (Fig. 6G). We have selected residue 
Tyr363 for mutation, since it seems key in the 
network of interactions as proposed above. Y363A 
mutation halves enzymatic activity (Fig. 6H). 
Unexpectedly, this decrease in activity is 
moderate. An explanation is that it corresponds to 
a single mutation among a multiple net of 
interactions and in a residue far from the active 
site. On the other hand, mIP5 2-K D2 and AtIP5 2- 
K D3 (Fig. 6C and 6D) are both involved in 
generation of the Zinc Sites which are not 
conserved either in sequence, location or structure 
between both enzymes. However, both sites seem 
to have a structural role, although we cannot 
discard any other additional function. Strikingly, 
the insertions found in mIP5 2-K (D2 and D3) 
interact with each other (Fig. 6E). Thus, Tyr368 in 
6 
 
 
 
 
mIP5 2-K and the following leucine residues 
(Leu372 and Leu374) interact with Leu281 and 
Leu283 located in D2 (Fig. 6E). A  double 
mutation in this region (L281A/L283A) reduces 
slightly the activity in contrast with the >90% 
decreases caused by the other mentioned mutation 
on a zinc binding residue (C291S) within this 
segment (Fig. 6H). All the mentioned leucine 
residues show very high conservation, except 
Leu283 as mentioned previously. A mutation in 
this residue would keep the capacity of making 
hydrogen bonds through its main chain (Fig. 6E) 
and the slight structural destabilization introduced 
has no impact in the protein active site. 
 
Novel findings in mammal IP5 2-K 
substrates binding and catalysis-Most residues 
involved in substrate binding and catalysis are 
conserved between mammal and plant IP5 2-Ks 
(Fig. 5). Nevertheless, we can observe some 
differences in the inositide P1 and P3  
coordination. As shown, inositide P1 interacts 
extensively with Arg100 of mIP5 2-K (Fig. 2C). 
The role of the Arg100 equivalent in AtIP5 2-K 
(Arg130) has been largely argued, and an 
implication in substrate binding and triggering of a 
productive protein conformation has been 
proposed (27,29,30). Unfortunately a construct 
prepared for R100A mIP5 2-K mutant did not  
show expression in the soluble fraction. However 
we can conclude that this residue is structurally 
similar to Arg130 in AtIP5 2-K. In mIP5 2-K, 
additional interactions with P1 are produced 
through the side chain of Lys173, a residue non- 
conserved with the plant IP5 2-Ks but absolutely 
conserved in mammal enzymes, whereas 
conservative substitutions can be observed in other 
vertebrates (Fig. 7). However, mutation of Lys173 
produces an enzyme as active as the wild type 
(Fig. 7A) showing very similar kinetic parameters 
(Fig. 3A), suggesting that this interaction is 
dispensable for substrate binding and it probably 
might have other implications, as will be 
commented later. 
Inositide P3 coordinates with the main 
chain of the G-loop in both enzymes, but different 
additional interactions are made within the two 
enzymes. In mIP5 2-K, P3 also interacts with the 
side chains of Asn18 and Lys19 G-loop residues 
whereas the plant enzyme provides two arginine 
residues   from   a   different   region   (Arg45  and 
 
Arg415) to complete this binding. Double  
mutation on the G-loop residues Asn18/Lys19 
(Fig. 7A) has a notable impact in the enzymatic 
activity, supporting a main role for these G-loop 
residues absolutely conserved in mammals (Fig. 
7C). 
We also can observe particular features in 
catalytic residues in the connecting loops (Fig. 
1B). We have prepared mutations on relevant 
residues from these CLs (K138A, D437A and 
D439A) (Fig. 2D), obtaining mutated enzymes 
with very low activities (Fig. 7B). The role of 
equivalent residues to Lys138 and Asp437 has 
been largely studied along the PKs and IPK 
families. These residues are responsible for 
neutralizing the negative charge developed in the 
transition state and orienting the nucleotide P 
through Mg ions respectively. We observe in mIP5 
2-K that Asp439 displays a strategic position, 
helping in Mg coordination and forming a bridge 
with Arg33, a residue involved in the coordination 
of nucleotide phosphates. Therefore it seems to 
provide a proper conformation for essential parts  
of the enzyme (Fig. 7B). No mutagenesis data has 
been reported on the Asp439 equivalent residues  
in other enzymes, since an homologous residue in 
this position is not present (neither in the IPK or 
PK families). Asp439 shows a  notable 
conservation in the whole IP5 2-K family across  
the species (Fig. 7C), showing only changes by a 
serine residue in some plant IP5 2Ks, which in turn 
also coordinates the Mg atom (25). We show here 
that D439A mutation produce nearly inactive 
enzyme. Finally, the connecting loop CL3 does  
not show significant conservation between mIP5 2- 
K and AtIP5 2-K, either in length or sequence, This 
loop is responsible in AtIP5 2-K for interactions 
between N- and C-lobe that might regulate 
partially the catalysis through opening and closing 
the active site (27). In addition this loop makes 
interactions with two residues directly involved in 
inositide binding, one of them (Arg130) shown to 
be essential for protein activity (27). We think that 
differences in this loop may also account for the 
differences observed in the Km from each protein. 
In mIP5 2-K structure, this loop is disordered and 
therefore interaction with the N-lobe has not been 
determined (Fig. 1). However, the flexibility found 
in the mIP5 2-K CL3 loop is consistent with a 
dynamic role and the previous proposed functions 
in catalysis regulation. 
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A prominent basic patch on mIP5 2-K 
surface-The structure of mIP5 2-K shows a very 
notable basic patch on its surface, mainly 
concentrated down the active site face of the 
enzyme (Fig. 8A). The enzyme regions that 
contribute to this patch are 6, 8 in CIP-I and the 
large insert found in CIP-II region. Interestingly, 
only a few of these basic residues are present or 
conserved in AtIP5 2-K (Fig. 8B), which  apart  
from the basic pocket for the inositide  binding 
does not show any significantly accumulation of 
arginine or lysine residues on its surface. By 
contrast, most of these residues are conserved 
across the mammal isoforms. This striking feature 
could be correlated with mammal IP5 2-K 
localization and/or other possible functions that 
this enzyme could present in cells. Particularly 
outstanding are two basic segments, one formed  
by residues Lys 175, Lys176 and Lys 179 and the 
other containing the residues in the new insert 
(D2) found in mammals and its preceding helix 
(Lys255, Arg259, Arg267, Lys275, Lys289 and 
Lys315). The first segment overlaps in part     with 
the motif 
173
KW K/R K/Q, highly conserved in 
mammals. The second segment encloses one of the 
main differences (D2) found with respect to plant 
enzymes. Based on the present finding, we 
propose that this insert, apart from supporting the 
zinc binding and stabilizing some protein regions, 
could be delineating a particular protein surface 
that could serve as an interface for other partners 
essential for IP5 2-K function. 
 
DISCUSSION 
Herein we described the first structure of a 
mammal IP5 2-K, a key enzyme in inositol 
metabolism with multiple impacts in diverse 
cellular events. Structural knowledge of this 
enzyme is essential to fully understand its  
function, although the fact that mammalian IP5 2- 
K shows extremely low bacterial expression and 
very low tendency to produce suitable crystals has 
precluded it up to now. The structure of mIP5 2-K 
presented here shows large structural differences 
with the AtIP5 2-K concentrated in the helical 
regions. Both enzymes are zinc metalloenzymes, 
the zinc sites showing different location and 
structural features. Whereas the plant zinc site is 
exclusive for its kingdom, the site found in 
mammals (Zn1) seems to be conserved in all    the 
 
species except plants. Punctual mutations of the 
Zn1 ligands present different effects, going from a 
null protein expression (Cys181) to a decreased 
zinc amount (Cys291) clearly correlated with a 
dramatic drop in protein activity and thermal 
stability. In particular, Cys291, located in a long 
insertion (D2), is present in all vertebrates and 
most invertebrates (not shown). This insertion is 
quite unusual since it is unstructured and placed 
between two contiguous helices (Fig. 6C). Its role 
seems to support the architecture of the CIP lobe, 
to complete the zinc binding site and to configure 
a markedly basic protein surface. 
Apart from these remarkable differences 
found, substrate recognition in both isoforms is 
quite similar. In previous works, AtIP5 2-K was 
shown to display conformational changes upon 
substrate binding that set the enzyme lobes 
together producing a closed conformation (27). 
Studies performed with AtIP5 2-K revealed that the 
IP5 binding to the C-lobe is stronger, while the 
binding to the N-lobe is necessary for protein 
activation and conformational change (30). As the 
Zn1 is located into the CIP-lobe and far from the 
N-lobe, we suggest that it would affect the 
preliminary inositide binding events rather  than 
the subsequent dynamic behavior of the protein. 
The structure solved for mIP5 2-K probably 
corresponds to the close conformation in  
agreement with the fact that the inositide substrate 
is present in the structure and the good 
superposition of mIP5 2-K reported here onto the 
AtIP5 2-K closed conformation. We do not know if 
the changes reported for AtIP5 2-K also occur in  
the mammal isoforms and if they are a general 
behavior of the IP5 2–K family. However, the 
conservation of several elements involved in these 
changes, as the flexibility of CL3 or inositide 
binding by N-lobe through Arg100 or G-loop, 
suggests that this open-close mechanism could be 
proposed for mammal IP5 2-Ks. In relation to this, 
we made proteolysis experiments to check if the 
substrates protect the enzyme digestion as 
happened in AtIP5 2-K (28). We observed no 
protection in mIP5 2-K, probably due to the fact 
that its digestion sites are far from  regions 
involved in the conformational change. Moreover, 
we did not get crystals in absence of substrates, 
which could be pointing to some structural  
changes though this is not conclusive either. 
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The structure of AtIP5 2-K revealed  that 
IP5 2-Ks are the most divergent among the IPK 
family, since it has the most elaborated CIP-lobe 
and binds the substrate in  very  different 
orientation to face an axial OH to P of phosphate. 
Similarly, IP5 2-Ks are the most  divergent  
enzymes classified inside the PK structural 
superfamily, what is confirmed in the here 
presented structure. Moreover, we observe that 
mIP5 2-K lacks the N-lobe acidic residue (Glu91, 
PKA nomenclature) reported to salt-bridge to a 
basic residue (Lys72, PKA nomenclature) and 
involved in ATP phosphate coordination. This 
bridge is a hallmark that identifies the protein 
kinases active conformation, and equivalent 
residues are also present in other IPKs. In contrast, 
mIP5 2-K has a different acidic residue, Asp439, 
which stabilizes Arg33 (equivalent to Lys72 in 
PKAs). Therefore, in IP5 2-K family this bridge 
could play a similar role to that described in PKs. 
Brehm and co-workers have investigated 
the human IP5 2-K and, in particular, the  
possibility of additional functions apart from its 
catalytic role (12,13). They found that hIP5 2-K 
colocalizes with mRNA, both in the nuclei and 
cytoplasm. (13). The mutations on a region rich in 
basic residues, coincident with the 
173
KW K/R  
K/Q   motif   conserved   in   mammals,   shows an 
altered enzyme ability to be exported out of the 
nuclei. This regions is exposed and included  
within the basic patch of mIP5 2-K identified in  
this work (Fig. 7C and 8). Interestingly, Lys173 at 
the beginning of the above motif coordinates the 
inositide substrate. However our mutagenesis 
experiments showed that this residue is  
dispensable for substrate binding, suggesting that 
the major role for this motif is played in the 
translocation process proposed by Brehm et al. 
(13). In addition, hIP5 2-K was shown to be a 
structural component of the nucleolus acting as a 
molecular scaffold in nucleoli and influencing the 
degree of rRNA synthesis, therefore having a role 
in rRNA biogenesis. In relation to this, hIP5 2-K 
interacts with three proteins (CK2, TCOF and 
UBF) that regulate rRNA synthesis. In   particular, 
UBF interacts with a basic region (
41
RKK motif 
equivalent to 
41
KKK motif in mIP5 2-K) (12) its 
mutation preventing the UBF translocation out of 
nucleolus after hIP5 2-K overexpression. As the 
authors predict, this region is completely exposed, 
and  we  observe  that  it  is  in  a  flexible  loop as 
 
shown by its poor electron density. We now 
disclose the high and specific basic region found  
in mammal IP5 2-Ks surface that could be used as  
a guide to find more target points. 
In conclusion, our work provides novel 
features for the IP5 2-Ks family and its mammal 
isoforms. Unexpected protein regions and residues 
have been identified providing an illuminating 
picture of these enzymes. The findings comprise 
the characterization of subtle but important  
features for substrate recognition, including 
unreported catalytic residues for this family, the 
identification of an unusual and exclusive zinc 
binding site and the conspicuous basic patch on  
the protein surface. Undoubtedly, the results 
obtained in this work provide a valuable tool for 
the design of therapeutics targeted at mammalian 
IP5 2-K with potential implications in health and 
also to perform IP5 2-K functional studies. Beyond 
catalytic function, our work also suggests putative 
regions of interaction of mammalian IP5 2-Ks with 
the cognate partners necessary to accomplish their 
precise functions. 
 
EXPERIMENTAL   PROCEDURES 
Protein expression and purification- 
Constructs for full length IP5 2-K recombinant 
expression either in bacteria (mipk1/pKLSLt 
plasmid) or insect cells were obtained as described 
by us (34) from a mipk1 cDNA (commercial clone 
bc062167). In order to produce a truncated mIP5 2- 
K enzyme lacking the 21 C-terminal residues (∆C- 
mIP5 2-K) a stop codon was introduced at position 
coding for residue 469 of mIP5 2-K by site directed 
mutagenesis and using as template the mipk1 
cDNA inserted into pKLSLt vector (35). Punctual 
and double ∆C-mIP5 2-K mutants were obtained  
by site directed mutagenesis using as template  the 
∆C-mipk1/pKLSLt plasmid. Primers used for 
construct preparations are shown in Table S3. 
Expression and purification of ∆C-mIP5 2- 
K samples fused to LSL- was performed similarly 
to the full-length samples (34). Briefly, the protein 
was expressed in E. coli BL21 Star (DE3) cells in 
2TY  medium  supplemented  with  kanamycin (50 
µg  ml  
-1
)  at  310  K  until  an  OD600  of  0.9      was 
reached. Expression was induced with 0.3 mM 
IPTG for 96 h at 283 K. Pellets were resuspended 
and sonicated in buffer A (20 mM Tris–HCl pH 
8.0, 150 mM NaCl, 1 mM DTT) plus 0.2 mM 
PMSF  and  0.05%   Triton  X-100.  The   filtrated 
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lysate was diluted 3-fold, loaded onto an heparin 
column, washed with buffer B (20 mM Tris HCl 
pH 8, 50 mM NaCl, 1 mM DTT) and eluted with a 
1M NaCl gradient. The fusion protein was applied 
onto a Sepharose CL-6B column equilibrated in 
buffer A and eluted using 200 mM lactose, 
followed by o/n cleavage with TEV protease 
(protease: protein mass ratio 1: 40) gently rolling 
at 278 K. Our protein was separated from LSLt 
and TEV protease by a second heparin column and 
further purified by size-exclusion chromatography 
(HiLoad 16/600 Superdex 200 column) 
equilibrated in buffer A plus 2mM IP6, which was 
included to avoid protein precipitation. All mIP5 2- 
K     samples     used     for     crystallization   were 
concentrated to around 5-6 mg ml 
-1 
and stored   at 
193 K. We obtained 1 mg of pure ∆C-mIP5 2-K  
per litre of bacteria culture. The purity of all the 
samples was confirmed by SDS–PAGE. For 
crystallization and CD analysis, WT and C291S 
ΔC-IP5 2-K samples were purified using this 
protocol. 
Finally, for activity assays, wild type 
LSLt-∆C-mIP5 2-K and mutants were purified as 
following. Clarified and filtrated cell lysate in 
buffer A was applied to a Sepharose CL-6B 
column equilibrated in buffer A. After washing 
with buffer A, the protein was eluted with 200 mM 
lactose. The sample was diluted 3-fold with 20 
mM Tris HCl pH 8.0, loaded onto an heparin 
column and washed with buffer B and eluted with 
a salt gradient. The protein in final buffer C (20 
mM Tris HCl pH 8.0, 700 mM NaCl, 1mM  DTT) 
was concentrated to 1-3 mg ml 
-1 
and stored at −80 
°C. 
 
Crystallization-All IP5 2-K samples used 
for crystallization were obtained in presence of 
2mM IP6. Best crystals obtained for the full-length 
mIP5 2-K expressed either in bacteria or in insect 
cells diffracted to 4-4.3 Å (34), which did not 
allowed the structure solution. Finally, ∆C-mIP5 2- 
K construct allowed us to improve resolution to 
3.2 Å from crystals grown in 0.2 M magnesium 
chloride, 0.1 M MES pH 6.25, 10% (v/v) PEG 
6000 and including 2 mM IP6 and 2 mM ADP in 
the protein buffer. A new pH grid screen using the 
sample in presence of 2mM IP6 allowed us to get 
better crystals grown in 0.2 M magnesium 
chloride, 0.1 M sodium acetate pH 5.5, 16% (v/v) 
PEG  6000.  Soaking  experiments  in   precipitant 
 
solutions containing 10 mM IP6 or 10  mM 
IP6/ADP during 3 hours yielded the complexes 
mIP5 2-K/IP6 and mIP5 2-K/IP5/ATP diffracting to 
2.4 Å in the last case. Microseeding technique was 
necessary to improve the quality of all these 
crystals. For this purpose, we selected our best 
crystals and introduced them into 50 l of 
crystallization solution plus a seeding bead. After 
two cycles of 30 s vortex and 30 s on ice, we made 
a seed stock. We streak-seed the crystallization 
drops with a whisker using this seed stock. All IP5 
2-K crystals appeared in a few hours after setting 
up the crystallization trials, and we observed that 
the protein is degraded in the crystallization 
conditions very quickly making crystal 
optimization extremely difficult. 
 
Data collection and structural 
determination- Crystals were transferred for a few 
seconds into precipitant solution plus 20% (v/v) 
glycerol and then flash-cooled in liquid nitrogen. 
Data from IP5 2-K crystals were collected at 100 K 
in beam line BL13-XALOC of ALBA synchrotron 
(36). ΔC-mIP5 2-K crystallizes in monoclinic P21 
space group in two different forms having one (pH 
5.5) or two molecules (pH 6.25) in the asymmetric 
unit (Table 1). Diffraction data were indexed, 
integrated and scaled using XDS (37) and merged 
using Aimless (38) from CCP4 suite (39,40). 
Initially, ΔC-mIP5 2-K monoclinic crystals grown 
at pH 6.5 (3.2 Å) allowed us to get a partial model 
using molecular replacement with MOLREP (41) 
and the structure of A. thaliana IP5 2-K as a search 
model (PDB code 2XAN). However the 
preliminary electron density maps presented many 
ambiguities, though clearly showed high positive 
difference peaks for two possible zinc ions. An 
anomalous map computed with PHENIX (42) 
showed a strong anomalous signal in those 
positions (Fig. S2). Therefore we tried SAD 
phasing in combination with MR (MRSAD-Auto- 
Rickshaw) (43). The heavy atoms positions were 
located using PHASER (44) and refined with 
MLPHARE (39). The phases obtained were then 
combined and density modification was performed 
with RESOLVE (45,46) and PIRATE (47).   Final 
electron density maps allowed the building of the 
whole chain except some exposed loops indicating 
the flexibility of these regions. 
Later, the ΔC-mIP5 2-K  monoclinic 
crystals grown at pH 5.5 allowed us to refine    the 
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structure of protein complexes with ligands  IP6 
and IP5/ATP to 2.6 Å and 2.4 Å maximum 
resolution, respectively. The structures were  
solved by molecular replacement using  MOLREP 
(41) and the coordinates of ΔC-mIP5 2-K  
described above as a search model. The 
substrates/products were manually fit into the 
electron density maps. Although we soaked the 
crystals with the products IP6/ADP, the initial 
electron density maps showed clear density 
consistent with IP5 and ATP (Fig. S1). Then, we 
checked that our crystallized mIP5 2-K samples are 
able to catalyze both the forward and reverse 
reactions in solution (Fig. 3B and C) and,  
therefore, we modeled the substrates IP5/ATP in 
the active site. Model refinement was performed 
with REFMAC (48) alternating with  manual 
model building using COOT (49). The 
stereochemistry of the model have been checked 
with PROCHECK (50). Statistics for all data 
processing and refinement are summarized in 
Table 1. Figures of the models were  generated 
with PYMOL (51). 
 
Circular dichroism-CD spectra were recorded 
using a Jasco-810 spectropolarimeter equipped 
with a Peltier-thermostatted cell holder. 
Measurements in the Far-UV region (250-200 nm) 
were performed using the samples WT and C291S 
ΔC-IP5  2-K  after  protein  buffer  exchange  to 25 
mM sodium phosphate pH 8 and at protein 
concentrations of 0.1 mg ml
-1 
(10 mm path-length 
quartz cells; bandwidth, 1 nm; response, 4 s; scan 
speed 20 nm min
-1)
). Collected spectra were the 
average  of  four  accumulations.  The  data    were 
converted to molar ellipticities after subtraction of 
the buffer contribution using the average  
molecular mass per residue (114 Da). Thermal 
denaturation was monitored by CD measuring the 
ellipticity changes at 220 nm as the temperature 
was raised (20-90 
o
C) at 60 
o
C  h
-1
. The    normalized 
ellipticity value at each temperature was calculated 
as ([]t – []25)/([]90 – []25), where []t is the 
ellipticity value at temperature t, and []25 and 
[]90 are the ellipticity values at 25 °C and 90 °C, 
respectively. 
 
Protein sequence alignments and 
bioinformatics-IP5 2-Ks sequences of all kingdoms 
have been retrieved using BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) and Pfam 
 
(52) searches. After removing all incomplete 
sequences or lacking essential hallmarks for kinase 
function, we had a collection of the following 
sequences: 102 for mammals, 142 for non  
mammal vertebrates, 28 for invertebrates, 158 for 
fungi and 203 for plants. Sequence alignments 
have been performed with CLUSTAL omega 
server (53) and corrected manually with SeaView 
(54). A structural alignment between AtIP5 2-K 
(code 1xan) and mIP5 2-K has been  performed 
with EPSPRIT (55) 
 
Enzyme assays-LSL-ΔC-IP5 2-K and ΔC- 
IP5 2-K samples showed comparable activity (not 
shown); therefore we used LSL tagged samples for 
analysis of kinetic parameters of WT and mutants. 
For this purpose, IP5-dependent conversion of 
ATP to ADP was determined by HPLC. Assays 
were performed in 20 mM Hepes, 1 mM MgCl2, 
pH 7.3 containing 0.2 – 5 µM Ins(1,3,4,5,6)P5  and 
50 µM ATP in a volume of 50-100  µl  at  an  
enzyme concentration of 4 µg ml
-1
. Reactions were 
stopped by the addition of 50 µl of 60 mM 
(NH4)2HPO4, pH 3.8 with H3PO4. Aliquots of the 
reaction products  were  resolved  by  ion-pair 
reverse    phase    chromatography    (56)    with   the 
following modifications: separations were 
performed on a 100 mm x 2.1 mm Agilent X- 
Bridge C18 (3.5 µm particle size) column eluted at 
a flow rate of 0.25 ml min
-1
. Nucleotide substrates 
and products (ADP and ATP) were detected at 260 
nm and the extent of conversion of one to the other 
determined from the ratio of integrated peaks. The 
ADP content of the ATP used was less than 0.1% 
of the ATP peak area. Reaction velocities were 
calculated assuming 1:1 stoichiometry of 
consumption of nucleotide and inositide. 
Experimental data were fitted by non-linear least 
squares regression to the Michaelis-Menten 
equation in GraFit (Erithacus Software). Assays 
were performed in triplicate and the experiment 
repeated an additional 3 times with similar results. 
 
 
Verification of reactions catalyzed by mIP5 
2-K-We undertook a variety of enzyme assays to 
determine the identities of products formed by the 
enzyme. We tested the ability of ΔC-mIP5 2-K to 
catalyze forward ‘kinase’ and reverse reactions. 
For the forward  ‘kinase’  reaction,  2.4  µg 
of ΔC-mIP5 2-K was incubated with 200 µl of 100 
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µM Ins(1,3,4,5,6)P5 (sodium salt, SiChem, 
Germany), 40 µM ATP in 20 mM Hepes, 1 mM 
MgCl2, pH 7.3 at 37°C. At intervals, aliquots were 
withdrawn and 20 µL injected onto a 250 mm x 3 
mm CarboPac PA200 column (Dionex) eluted at a 
flow rate of 0.4 ml min
-1 
with a gradient derived 
from buffer reservoirs containing: A, water; B 0.6 
M    methanesulfonic    acid    according    to     the 
following profile: time (min), % B; 0, 0; 25, 100; 
38, 100. The eluate from the column was mixed in 
a  mixing  tee  with  colour-reagent  (0.1  %     w/v 
Fe(NO3)3.9H2O in 2% v/v HClO4, after (57) 
delivered at a flow rate of 0.2 ml min
-1 
by a second 
hplc pump. The combined flow was monitored at 
290 nm after passage through a knitted reaction 
coil. 
For the reverse reaction, 2.4 µg of ΔC- 
mIP5 2-K was incubated with 200 µl of 100µM IP6 
(sodium salt, Merck, Germany), 50 µM ADP in 20 
mM Hepes, 1 mM MgCl2, pH 7.3 at 37°C, with 
subsequent processing as above. The identity of 
IP5 and IP6 products was confirmed by 
chromatography of standards (SiChem or Merck) 
and by analysis of an IP6 hydrolyzate obtained by 
overnight refluxing of IP6 in 1M-HCl, with 
subsequent rotary evaporation to remove HCl. 
 
Our Ins(1,3,4,5,6)P5 [IP5 2-OH] substrate 
contained D- and/or L-Ins(1,2,4,5,6)P5 [IP5 1/3- 
OH], but our analysis which resolves the two 
meso-compounds (IP5 2-OH and IP5 5-OH)  from 
the two pairs of enantiomers (IP5 1/3-OH and IP5 
4/6-OH) confirmed that mIP5 2-K is an inositol 
1,3,4,5,6-pentakisphosphate 2-kinase that does not 
accept D- and/or L-Ins(1,2,4,5,6)P5 (mixture 
unknown) as substrate (Fig. 3B). HPLC traces 
were exported from Jasco (Great Dunmow, UK) 
ChromNav software as asci files and redrawn in 
GraFit (Erithacus Software). 
 
Inductively Coupled Plasma-Optical 
Emission Spectroscopy-Metal analysis of mIP5 2-K 
was performed by optical emission spectroscopy 
on a Varian Vista Pro ICP-OES. Protein or buffer 
in which protein was prepared were diluted 125- 
139 fold in 18.2 MOhm.cm water containing 1N 
HNO3. Diluted protein or buffer were subjected to 
ICP-OES on a machine calibrated with 0–4.0 µM 
standards of Co, Cu, Ni, and Zn in 1N HNO3. All 
metals except zinc were close to the limit of 
detection in the diluted protein sample; they were 
only slightly above the background in the buffer 
(Table S2). 
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The abbreviations used are: IP, Inositol phosphate; IP5, Inositol 1,3,4,5,6-pentakisphosphate; IP5 2-K, 
Inositol 1,3,4,5,6-pentakisphosphate 2-kinase; IP6, Inositol hexakisphosphate; IPK, Inositol polyphosphate 
kinase; LSL, Laetiporus sulphurous lectin; PEG, Polyethylene glycol; PMSF, Phenylmethanesulfonyl- 
fluoride; TEV, Tobacco Etch Virus; CK2, protein kinase CK2; TCOF1, treacle protein; UBF, upstream 
binding factor. 
 
Supplemental data includes Figure S1 and S2 and Tables S1-S3. 
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Table 1. Crystallographic data statistics and refinement 
 ΔC-mIP5 2-K ΔC-mIP5 2-K ΔC-mIP5 2-K 
Ligand modeled +IP5 + ATP +IP6 + IP5 +ATP 
Crystallization pH 6,25 5,50 5,50 
Data collection and processing    
Space group  P 21 P 21 P 21 
Unit Cell a, b, c (Å) 64.62, 140.76, 68.66 60.55, 71.64, 61.82 60.16, 71.50, 61.20 
Unit Cell α, β, γ (Å) 90.0, 106.5, 90.0 90.0, 111.7, 90.0 90.0, 111.4, 90.0 
Temperature (K)  100 100 100 
Radiation source  Synchrotron Synchrotron Synchrotron 
Wavelength (Å)  0.979490 0.979260 0.979260 
Resolution range (Å) 49.86 - 3.20 (3.42 - 3.20) 44.82 - 2.54 (2.65 - 2.54) 71.50 - 2.40 (2.49 - 2.40) 
Nº observed reflections 1 34008 (24350) 106382 (13008) 123314 (13608) 
Nº Unique reflections  19318 (3482) 16270 (1970) 18528 (1961) 
Multiplicity  6.9 (7.0) 6.5 (6.6) 6.7 (6.9) 
Data completeness (%)  99.3 (99.0) 99.6 (99.7) 97.3 (99.8) 
Matthews coef. (Å3 Da-1)  2.32 2.32 2.30 
Nº of molecules in a.u.  2 1 1 
Wilson B factor (Å 2)  83.26 54.65 45.72 
Mean I/σ (I)  14.7 (3.3) 12.5 (3.1) 14.9 (3.5) 
Rmerge (%) †  10.4 (63.5) 7.6 (58.8) 7.3 (52.8) 
Rpim (%) ††  4.3 (25.8) 3.2 (24.6) 3.1 (21.5) 
CC1/2  0.99 (0.89) 0.99 (0.99) 0.99 (0.97) 
Refinement     
Resolution range (Å)  70.37 - 3.20 57.45 - 2.60 56.99 - 2.40 
Rwork / Rfree††† (%)  22.51/ 24.53 25.34/ 28.95 24.10/ 27.12 
Nº of atoms/ Bav (Å2)  6647/ 103.43 3348/ 69.36 3451/ 52.81 
Protein  6575/ 103.15 3285/ 69.65 3342/ 53.178 
Ligand  63/ 153.38 36/ 64.72 63/ 44.77 
Zinc  4/ 79.47 1/ 46.91 1/ 49.87 
Mg  2/ 102.48 - 2/ 38.56 
Water molecules  3/ 51.26 26/ 39.60 39/ 35.34 
Ramachandran plot (%) 
Favoured /outliers 88.8/ 0.0 92.8/ 0.3 91.7/ 0.3 
r.m.s. deviations 
Bonds/Angles (Å/º) 0.007/1.18 0.008/1.29 0.006/1.22 
PDB accession codes 5MWL 5MWM 5MW8 
Missing residues in pdb A: 1-4/99-102/221-225/296-311/413- 
426/465-468 
1-9/40-41/122-128/221-228/244- 
248/298-310/411-419/465-468 
1-4/41-42/122-128/221-228/244- 
245/296-310/411-419/465-468 
 B: 1-7/36-43/97-105/221-226/244-   
 251/277-278/298-311/412-426/464-468   
†Rmerge = ∑hkl ∑i | Ii(hkl) – [I(hkl)]| / ∑hkl ∑i  Ii(hkl), where Ii(hkl) is the measurement of reflection hkl and [I(hkl)] is the weighted mean of all 
measurements. 
††Rpim = ∑hkl [1/(N - 1)] 1/2 ∑i | Ii(hkl) – [I(hkl)]| / ∑hkl ∑i  Ii(hkl), where N is the redundancy for the hkl reflection. 
†††Rwork / Rfree = ∑hkl | Fo – Fc | / ∑hkl | Fo |, where Fc is the calculated and Fo is the observed structure factor amplitude of reflection hkl for the 
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working / free (5%) set, respectively. 
 
FIGURE LEGENDS 
 
FIGURE 1. Structure of mIP5 2-K. A, cartoon representation of the structure of mIP5 2-K. The N-lobe 
and C-lobe are shown in orange-brown and blue colors respectively. ATP and IP5 are shown as green 
sticks, highlighting the O, N and P atoms in red, blue and orange respectively. The Zn and Mg ions as red 
and green spheres respectively. The left inset shows a second Zinc Site found in one of the complexes. 
The dashed lines show disordered regions. In the right, the five helical segments found in mIP5 2-K are 
detailed. B, Arrows indicate -strands and rectangles the alpha helices. The connecting loops between C- 
lobe -sheet and CIP-lobe are highlighted in grey. Conserved sequence motifs within the IPK family   are 
concentrated in the CLs--strands connections (CL1:
136
EIKPK; CL2: 
206
QNNXRXF; CL3:variable in 
sequence and length; CL4: 
400
DCSIMI and CL5: 
436
LDLDLK). 
 
FIGURE 2. Substrate recognition by mIP5 2-K. A, a zoom of Fig. 1A showing the substrates ATP and 
IP5 and the residues involved in their recognition as sticks in light orange (N-lobe), blue (C-lobe) and grey 
(CLs in C-lobe). B, a zoom showing the nucleotide site. Water molecules are shown as red spheres. C, a 
zoom showing the inositide site. D, a zoom showing inositide and nucleotide interaction. 
 
FIGURE 3. Enzyme assays and reaction catalyzed by mIP5 2-K samples. A, Kinetic parameters of 
LSLt-mIP5 2-K WT and of K173A variant. B, kinase reaction catalyzed by mIP5 2-K. Products of enzyme 
assays resolved by ion exchange HPLC: substrate, Ins(1,3,4,5,6)P5 (IP5) (upper panel); and reaction 
products after 60 min (middle panel) and 260 min (lower panel) of incubation of IP5 and ATP with 
enzyme. C, reversibility of reaction catalyzed by mIP5 2-K. Products of enzyme assays resolved by ion 
exchange HPLC: substrate, IP6 (upper panel), reaction products after 110 min (upper middle panel) and 
310 min (lower middle panel) of incubation of IP6 and ADP with enzyme. The lower panel shows inositol 
phosphate (IP) standards obtained by acid hydrolysis of IP6. 
 
FIGURE 4. Zinc binding sites located in mIP5 2-K complexes. A, a cartoon representation of mIP5 2-K 
Zn1 site and B, of Zn2 site. C, plot of IP5 dependent conversion from ATP to ADP of mIP5 2-K WT and 
mutants of the zinc binding residues. Error bars show the standard deviation. D, zinc content of mutated 
mIP5 2-K samples relative to WT mIP5 2-K. E, Far-UV CD spectra (left) and  thermal  denaturation 
followed by CD (right) of WT (black squares) and C291S (blue circles) ∆C-mIP5 2-K. 
 
FIGURE 5. Structural alignment of mIP5 2-K vs AtIP5 2-K. The secondary structure is shown on top 
(mammal enzyme) and bottom (plant enzyme). Identical regions are red-shaded, while similar regions are 
shown in red letters. Light-green shaded squares show regions with a divergent structure in both enzymes. 
Helical regions inserted into the -sheet cores are marked as dashed lined boxes. 
 
FIGURE 6. Novel regions of mIP5 2-K and structural comparison with AtIP5 2-K. A, a cartoon 
representation of mIP5 2-K (white) and AtIP5 2-K (wheat) superposed structures. Zinc ions are shown as 
dark blue (mIP5 2-K) and cyan (AtIP5 2-K) spheres. Mg ions are shown as spheres in similar color to the 
isoform they belong. The main differences between both samples (D1, D2 and D3) are highlighted in 
different colors. B, representation of N-lobes from both isoforms highlighting D1 (green) insertion in 
AtIP5 2-K. C, a piece of CIPII lobe showing D2 in mIP5 2-K (blue). D, A view showing D3 (magenta in 
mIP5 2-K and cyan in AtIP5 2-K). E, intramolecular interactions produced by D2 in mIP5 2-K. Blue, pink 
and yellow sticks show residues from D2, D3 and the rest of the protein respectively. F, intramolecular 
interactions produced by D3 in mIP5 2-K. G, intramolecular interactions produced by D1 in AtIP5 2-K. 
Green sticks show residues from D1. H, plot of IP5 dependent conversion of ATP to ADP of WT mIP5 2-K 
and several mutants of residues located in the different regions. Error bars show the standard deviation. 
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FIGURE 7. Analysis of relevant residues for mIP5 2-K function. A, plot of IP5 dependent conversion of 
ATP to ADP by mIP5 2-K WT and several mutants to determine the effect of selected inositide binding 
residues. Error bars show the standard deviation. B, same as A to check the effect of catalytic residues. 
The squared picture illustrates the salt-bridge between Asp439 and Arg33. C, IP5 2-K sequence 
conservation across the kingdoms in regions comprising the mutated residues (Asn18 and Lys19; Arg173 
and Asp439). Letter X and asterisks denote residues non-conserved or mostly full conserved respectively. 
Abbreviations: MAM: mammals, VER: vertebrates other than mammals, INV: invertebrates, FUN: Fungi, 
PLA: Plants. 
 
FIGURE 8. Basic patch on mIP5 2-K surface. A, electrostatic surface representation of  mIP5 2-K 
showing its exposed basic patch. Residues conserved and non conserved with the AtIP5 2-K are shown in 
yellow and white respectively. B, same representation as in A for the AtIP5 2-K enzyme. 
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Nucleo tide  b ind ing res idue 
  Inos it ide   b ind ing  res idue  
 Inos i t ide  and  nuc leo tide   b ind ing  res idue   
 Zinc b inding res idue s i te  1 mIP52K    
Zinc b inding res idue s i te 2     mIP52K  
 Zinc  b inding  res idue  A t IP52K  
   
mIP52K 397 TAKDCSIMI ALSPCLQGT S SDQRPVIPSS..RSRLAFS V SV 
AtIP52K 365 TAKDCSIMI SFQSRNAWD S EPSGDYVSLKPTNQTFDYK V HF 
    
  CIPIII  
 
mIP52K 
 
467 
 
  
KDDTVRSTRFKEHEDCTLVLHKV  
 
AtIP52K  .......................   
 
 
..SEEILQHLQNIVDFG KNV MKDF LG ENY V HC 
NELISSPNKEVLEQRYV KNV IIPL LG PKH V DA 
  
motif I 
 
 
 
KPKCGF I P F S NDVT..HEM K HK V C R YC MHQ H LK VATGKWKKI S K Y C PL 
KPKCGF L P T S RFIGKENML K TS V S R FK MHQ L LK LEYNEISEE S E Y D PL 
  
 
 
motif IV 
 
L DL D LKP YESIPHQ YKLD S KI VNY Y SKTVH A 
I DL S LKP LKRMESY YKLD K KI ISF Y NRKQK A 
  
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E F 
F66 
 
 
1 
 
 
 
 
 
 
 
 
 
F58 
 
 
 
 
Y368 
 
 
 
 
 
L440 
 
 
 
D3 
 
 
 
 
F367 
R393 
 
 
 
 
 
13 
 
G 
 
 
 
 
Y443 
Y363  
 
 
E444 
I359 
14 
R354 
L361 
Y88 
W69 D1 
L410 
L75 
A B 
D1 
1 
2 
C 
6 
8 
Zn1 
5 D2 
9 
2 
D12 D3 D3 
13 
Zn 
10 
11 
H 
25 
 
 
 
Figure 7 
 
A B C  
  
MAM  G E G  N  K S 
VER G* E*G* N (K>Q=R)S* 
INV (G>A)*E G (N>R)*  X X 
FUN  X X G  X  X X 
PLA G* E*G*(A>G>V)*(A>V)* N* 
 
  
MAM  K W (K>R>Q) (Q>K) I S (K>R)* 
VER  K*W*(K>R)*  (R>K)*X S X 
 
MAM  L D L  D  L K 
VER  L D L  D (L>P)K 
INV  X D L D*  X K 
FUN  X D X  D  X K 
PLA (I>L>V)D L*(D>S)*X (K>R) 
173-KWKK motif 
G-loop: 15-GEGNKS 
CL5: 436-LDLDLK motif 
CL5 
R33 
D437 
D439 
Mg2 
Mg1 
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